TITLE

A Preliminary Investigation of Balloon Angioplasty versus Surgical Treatment of Thrombosed Dialysis Access Grafts

AUTHOR(S)
McCutcheon, Brion; Weatherford, David; Maxwell, Gary; Hamann, Mary Sue; Stiles, Anquonette
PUB. DATE
August 2003
SOURCE
American Surgeon;Aug2003, Vol. 69 Issue 8, p663
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
It has been estimated that 180,000 patients in the United States have end-stage renal disease requiring hemodialysis, and this number is currently increasing at a rate of 10 per cent per year. With the growing number of patients requiring hemodialysis the insertion and maintenance of dialysis access has become a common task for vascular surgeons. In fact dialysis access is now the most common vascular operation and may account for as much as 40 to 50 per cent of the practice of a busy vascular surgeon. The two major techniques for repairing thrombosed dialysis access grafts are open surgical revision and balloon angioplasty. Surgical revisions of access sites include patch angioplasty and interposition jump grafts. Balloon angioplasty involves declotting the graft mechanically or chemically followed by dilation of the stenotic segment by an angioplasty balloon under fluoroscopy. Few studies have compared the two methods of repair, and the studies that have been done reveal conflicting results. A retrospective chart review of patients treated at the New Hanover Regional Medical Center for repair of thrombosed dialysis access grafts was conducted. The final sample available for analysis consisted of 16 patients with balloon angioplasty and 44 patients with surgical revision. These two groups were compared in terms of demographics, past medical history, surgery time, complications, length of stay, length of graft patency, and typical costs. Overall balloon angioplasty as compared with surgical revision was associated with longer patency (5.5 vs 3.2 months), shorter surgical time (43.9 vs 64.5 minutes), shorter length of hospital stay (less than one day vs one day or more), and fewer complications (12% vs 30% of the patients)....
ACCESSION #
11086456

 

Related Articles

  • Fistulogram after Arteriovenous Dialysis Graft Thrombectomy Should be Mandatory. KUMAR, SHAKTHI D.; JAIN, KRISHNA M.; JAIN, SHIKHA; MUNN, JOHN S.; RUMMEL, MARK C. // American Surgeon;Dec2008, Vol. 74 Issue 12, p1154 

    The purpose of this study was to determine if fistulogram after prosthetic arteriovenous dialysis graft thrombectomy would reveal underlying lesions, which need correction, and if revision would improve graft patency. One hundred and ninety-two open thrombectomy procedures in 61 patients from...

  • KIDNEY DIALYSIS AT HOME. Harrar, Sari; L.T. // Prevention;Sep2002, Vol. 54 Issue 9, p166 

    Focuses on the Aksys PHD Personal Hemodialysis System, a drug-free dialysis system, which has been approved by the U.S. Food & Drug Administration. Way that the system allows those with chronic kidney disease to perform short daily dialysis.

  • Journal of the American Society of Nephrology: Intensive kidney dialysis indicates better survival rates than conventional dialysis.  // Biomedical Market Newsletter;4/28/2012, Vol. 21, p1 

    The article discusses a study from the U.S. Lawson Health Research Institute on patients suffering with end-stage renal disease which shows that patients undergoing intensive dialysis at home rather than the conventional dialysis in clinics have better chances of survival.

  • Proteon Adds $15M; Getting Closer to Novartis Option.  // Bioworld Week;8/22/2011, Vol. 19 Issue 33, p2 

    The article reports on the 15.2 million U.S. dollars worth of funds from Proteon Therapeutics Inc. for Novartis AG's Phase II study of lead product PRT-201, a recombinant human elastase. It states that the purpose of the drug is to make successful a surgical procedure in chronic kidney disease...

  • Replacement of Renal Function in Intensive Care Unit Patients. Marneras, Christos; Karpouhtsi, Irene // Nosileftiki;Apr2009, Vol. 48 Issue 2, p173 

    During the last twenty years, there has been a trend for novel techniques, such as the continuous renal replacement treatment (CRRT) method to replace the classic intermittent haemodialysis (IHD) method in the treatment of seriously ill patients suffering from acute renal failure hospitalized in...

  • Expert Commentary. Dougherty, Matthew J. // Perspectives in Vascular Surgery & Endovascular Therapy;Jan2004, Vol. 16 Issue 1, p50 

    The article comments on a study on hemodialysis access. Several centers in the U.S. have recommended the nearly universal use of primary fistulas. Several factors should be considered when assessing the relative benefits of autogenous access creation, and particularly basilic vein transposition,...

  • Book Review: Vascular Access: Principles and Practice–5th Edition. Hodgkiss-Harlow, Kelley D. // Vascular & Endovascular Surgery;Nov2011, Vol. 45 Issue 8, p775 

    The article reviews the book "Vascular Access: Principles and Practice," fifth edition edited by Samuel Eric Wilson.

  • Patients with Fabry disease on dialysis in the United States. Thadhani, Ravi; Wolf, Myles; West, Michael L.; Tonelli, Marcello; Ruthazer, Robin; Pastores, Gregory M.; Obrador, Gregorio T. // Kidney International;Jan2002, Vol. 61 Issue 1, p249 

    Patients with Fabry disease on dialysis in the United States.. Background: Fabry disease results from an X-linked deficiency of lysosomal alpha-galactosidase A and is a rare cause of end-stage renal disease. Little is known about the characteristics of patients with Fabry disease that initiate...

  • An Ethical Dilemma: Should Expensive Care Be Rationed?  // Kidney;Jan/Feb98, Vol. 7 Issue 1, p13 

    Evaluates the clinical outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care for seriously ill renal patients. Median duration of survival; Estimated cost per quality-adjusted life-year saved with dialysis and continuing care rather than withholding dialysis and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics